Clinical Trials for Veloxis Pharmaceuticals

Explore 11 clinical trials worldwide

Showing 1-11 of 11 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Veloxis Pharmaceuticals

Clinical Trials (11)

NCT06751992
Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients
PHASE4Not yet recruiting
92 participants
Started: May 1, 2025 · Completed: Oct 1, 2027
2 conditions2 sponsors1 location
NCT04469842
Early Use of Long-acting Tacrolimus in Lung Transplant Recipients
EARLY_PHASE1Recruiting
48 participants
Started: Dec 1, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04773392
Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR
PHASE4Recruiting
80 participants
Started: Nov 23, 2021 · Completed: Feb 28, 2025
2 conditions2 sponsors1 location
NCT04838288
Cognitive Outcomes in Stable Renal Transplant Patients Switched FromTacrolimus to Envarsus XR™
PHASE4Active, not recruiting
60 participants
Started: Jun 22, 2021 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT03841097
Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants
PHASE4Active, not recruiting
60 participants
Started: Nov 11, 2019 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT03979365
Envarsus XR Compared to Immediate Release Tacrolimus
PHASE4Active, not recruiting
240 participants
Started: Jul 18, 2019 · Completed: Jul 31, 2025
1 condition2 sponsors3 locations
NCT03321656
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
PHASE2/PHASE3Recruiting
78 participants
Started: Mar 28, 2019 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT03769298
CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients
PHASE2/PHASE3Recruiting
20 participants
Started: Feb 27, 2019 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT03266393
Envarsus XR® in Adolescent Renal Transplant Recipients
PHASE4Active, not recruiting
28 participants
Started: Jan 15, 2019 · Completed: Mar 31, 2023
3 conditions2 sponsors1 location
NCT04665310
Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant
PHASE4Active, not recruiting
46 participants
Started: Sep 1, 2018 · Completed: Oct 31, 2025
3 conditions2 sponsors0 locations
NCT03386305
Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant
PHASE2/PHASE3Active, not recruiting
35 participants
Started: Dec 13, 2017 · Completed: Dec 31, 2021
1 condition2 sponsors1 location